Zobrazeno 1 - 10
of 371
pro vyhledávání: '"Stypinski D"'
Autor:
Yap TA; The University of Texas MD Anderson Cancer Center, Houston., Bardia A; Massachusetts General Hospital, Boston., Dvorkin M; Clinical Oncology Dispensary, Budget Healthcare Institution of Omsk Region, Omsk, Russian Federation., Galsky MD; Icahn School of Medicine at Mount Sinai, New York, New York., Beck JT; Highlands Oncology Group, Springdale, Arkansas., Wise DR; NYU Laura and Isaac Perlmutter Cancer Center, New York, New York., Karyakin O; Medical Radiological Research Center, Kaluga, Russian Federation., Rubovszky G; National Institute of Oncology, Budapest, Hungary., Kislov N; Yaroslavl Regional Cancer Hospital, Yaroslavl, Russian Federation., Rohrberg K; Department of Oncology, Phase I Unit, Rigshospitalet, Copenhagen, Denmark., Joy AA; Cross Cancer Institute, Department of Oncology, University of Alberta, Edmonton, Canada., Telli ML; Stanford University School of Medicine, Stanford, California., Schram AM; Memorial Sloan Kettering Cancer Center, New York, New York., Conte U; Pfizer, New York, New York., Chappey C; Pfizer, San Francisco, California., Stewart R; Now with Translational Medicine, Oncology at AstraZeneca, Cambridge, United Kingdom.; Pfizer, San Diego, California., Stypinski D; Pfizer, San Diego, California., Michelon E; Pfizer, New York, New York., Cesari R; Pfizer, Milan, Italy., Konstantinopoulos PA; Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
JAMA oncology [JAMA Oncol] 2023 Jan 01; Vol. 9 (1), pp. 40-50.
Autor:
Jans HS; Department of Oncology, University of Alberta, Edmonton, AB T6G 1Z2, Canada., Stypinski D; Pfizer Inc., New York, NY 10017, USA., Kumar P; Department of Oncology, University of Alberta, Edmonton, AB T6G 1Z2, Canada., Mercer JR; Department of Oncology, University of Alberta, Edmonton, AB T6G 1Z2, Canada., McQuarrie SA; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada., McEwan AJB; Ariceum Therapeutics GmbH, 13125 Berlin, Germany., Wiebe LI; Department of Oncology, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2022 Aug 09; Vol. 14 (8). Date of Electronic Publication: 2022 Aug 09.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Stypinski D; Clinical Pharmacology, Oncology, GPD, Pfizer Inc, San Diego, California, USA., Fostvedt L; Clinical Pharmacology, Oncology, GPD, Pfizer Inc, San Diego, California, USA., Lam JL; Pharmacokinetics, Dynamics and Metabolism, WRD, Pfizer Inc, San Diego, California, USA., Vaz A; Pharmacokinetics, Dynamics and Metabolism, WRD, Pfizer Inc, San Diego, California, USA., Johnson TR; Pharmacokinetics, Dynamics and Metabolism, WRD, Pfizer Inc, San Diego, California, USA., Boerma JS; Unilabs York Bioanalytical Solutions Ltd, Sandwich, Kent, UK., Pithavala YK; Clinical Pharmacology, Oncology, GPD, Pfizer Inc, San Diego, California, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2020 Sep; Vol. 60 (9), pp. 1254-1267. Date of Electronic Publication: 2020 May 22.
Autor:
Ahmed MA; Center of Drug Evaluation and Research, US Food and Drug Administration., Patel C; Quantitative Clinical Pharmacology, Takeda Pharmaceutical International Company Ltd., Drezner N; Center of Drug Evaluation and Research, US Food and Drug Administration., Helms W; Center of Drug Evaluation and Research, US Food and Drug Administration., Tan W; Global Clinical Pharmacology, Pfizer Inc, San Diego, California, USA., Stypinski D; Global Clinical Pharmacology, Pfizer Inc, San Diego, California, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2020 Jan; Vol. 13 (1), pp. 31-40. Date of Electronic Publication: 2019 Oct 31.
Autor:
Stypinski D; Pfizer Inc., Clinical Pharmacokinetics, Pfizer Inc., New York, NY 10017, USA. Daria.Stypinski@pfizer.com., McQuarrie SA; PET Centre, Department of Oncology, University of Alberta, 11560 University Ave, Edmonton, AB T6B 1Z2, Canada. smcquarr@ualberta.ca.; Faculty of Pharmacy and Pharmaceutical Sciences, and Department of Oncology, University of Alberta, Edmonton T6G 2R3, Canada; 2-40 Medical Isotope & Cyclotron Facility, University of Alberta-South Campus, Edmonton, AB T6H 2V8, Canada. smcquarr@ualberta.ca., McEwan AJB; PET Centre, Department of Oncology, University of Alberta, 11560 University Ave, Edmonton, AB T6B 1Z2, Canada. sandy.mcewan@albertahealthservices.ca., Wiebe LI; PET Centre, Department of Oncology, University of Alberta, 11560 University Ave, Edmonton, AB T6B 1Z2, Canada. Leonard.wiebe@ualberta.ca.; Faculty of Pharmacy and Pharmaceutical Sciences, and Department of Oncology, University of Alberta, Edmonton T6G 2R3, Canada; 2-40 Medical Isotope & Cyclotron Facility, University of Alberta-South Campus, Edmonton, AB T6H 2V8, Canada. Leonard.wiebe@ualberta.ca.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2018 Feb 22; Vol. 10 (1). Date of Electronic Publication: 2018 Feb 22.
Autor:
Miura, Atsuko1,2 (AUTHOR), Narita, Yukihiko1 (AUTHOR), Sugawara, Taku2 (AUTHOR), Shimizu, Hiroaki1 (AUTHOR), Itoh, Hideaki3 (AUTHOR) itohh@g.ecc.u-tokyo.ac.jp
Publikováno v:
International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 12, p6452. 11p.
Autor:
Crișan, George1,2 (AUTHOR) george.crisan@scjucluj.ro, Stan, Ștefan1 (AUTHOR) stefan.stan@ubbcluj.ro, Chiș, Vasile1,3 (AUTHOR) vasile.chis@ubbcluj.ro
Publikováno v:
Molecules. Apr2024, Vol. 29 Issue 7, p1505. 19p.
Autor:
Marshall, W.L., Yeh, W.W., Stypinski, D., Auger, P., Bethel-Brown, C., Caro, L., Jumes, P., Huang, X., Guo, Z., Martinho, M., Feng, H.-P., Armas, D., Brejda, J., Iwamoto, M., Butterton, J.R.
Publikováno v:
In Journal of Hepatology April 2015 62 Supplement 2:S686-S686
Autor:
Khalilieh S; Merck & Co., Inc., Kenilworth, NJ, USA., Yee KL; Merck & Co., Inc., Kenilworth, NJ, USA., Liu R; Merck & Co., Inc., Kenilworth, NJ, USA., Fan L; Merck & Co., Inc., Kenilworth, NJ, USA., Sanchez RI; Merck & Co., Inc., Kenilworth, NJ, USA., Auger P; Celerion, Lincoln, NE, USA., Triantafyllou I; Merck & Co., Inc., Kenilworth, NJ, USA., Stypinski D; Celerion, Lincoln, NE, USA., Lasseter KC; Clinical Pharmacology of Miami, Inc., Miami, FL, USA., Marbury T; Orlando Clinical Research Center, Orlando, FL, USA., Iwamoto M; Merck & Co., Inc., Kenilworth, NJ, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2017 Jun; Vol. 57 (6), pp. 777-783. Date of Electronic Publication: 2016 Dec 27.